UCB FARCHIM SA - EDELWEISS
Pharmaplan as EPCMV partner for UCB has designed and built one of the largest biotech production facilities in Europe within 28 months. Two years after successful hand-over, Pharmaplan supported UCB again for the production capacity increase for Cimzia™ to 1,000 kg/year.
UCB’s new greenfield facility for antibody production against rheumatoid arthritis is the main production center for Cimzia™. It is fitted with ultra-modern laboratories and a highly automated production line. One of the main challenges was the ambitious schedule, that aimed fast track finalization in 28 months from conceptual design to operational qualification.